Articles from Biotech Insider

AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

News Provided by Biotech Insider on behalf of MindWalk Holdings Corp.

By Biotech Insider · Via GlobeNewswire · October 14, 2026

Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick

A look at the three approaches competing to help beta cell replacement survive the immune system

By Biotech Insider · Via GlobeNewswire · September 8, 2026

Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It

News Provided by Biotech Insider on behalf of Conexeu Sciences Inc.

By Biotech Insider · Via GlobeNewswire · August 11, 2026

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

Issued on behalf of Conexeu Sciences Inc.

By Biotech Insider · Via GlobeNewswire · July 1, 2026

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

Issued on behalf of Conexeu Sciences Inc.

By Biotech Insider · Via GlobeNewswire · June 25, 2026

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

Issued on behalf of Conexeu Sciences Inc.

By Biotech Insider · Via GlobeNewswire · June 18, 2026

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet

Issued on behalf of GT Biopharma, Inc. (Nasdaq: GTBP)

By Biotech Insider · Via GlobeNewswire · June 8, 2026

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

Issued on behalf of Conexeu Sciences Inc.

By Biotech Insider · Via GlobeNewswire · May 27, 2026